Livongo Integrates Access to Telehealth in Support of People Living with Chronic Conditions
Connects with leading telehealth companies to make it easier for Members to access virtual acute and primary care cliniciansMOUNTAIN VIEW, […]
The RealReal Announces Timing of its Third Quarter 2019 Earnings Results Conference Call
SAN FRANCISCO, Oct. 28, 2019 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, consigned luxury […]
MKS Instruments to Present at the Robert W. Baird & Co. 2019 Global Industrial Conference
ANDOVER, Mass., Oct. 28, 2019 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable […]
Fortinet Acquires Advanced Endpoint Security Company enSilo
SUNNYVALE, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) —Ken Xie, Founder, Chairman of the Board, and CEO, Fortinet“As businesses become more […]
LPL Financial Welcomes Petricic & Phillips Financial Group
CHARLOTTE, N.C., Oct. 28, 2019 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm and independent broker-dealer, […]
Net1 to Host Conference Call to Review First Quarter 2020 Results
JOHANNESBURG, South Africa, Oct. 28, 2019 (GLOBE NEWSWIRE) — Net 1 UEPS Technologies, Inc. (NasdaqGS: UEPS; JSE: NT1) (“Net1”) today […]
Collectors Universe to Announce First Quarter of Fiscal Year 2020 Financial Results on October 31, 2019
NEWPORT BEACH, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) — Collectors Universe, Inc. (NASDAQ: CLCT), a leading provider of value-added authentication […]
Y-mAbs Announces Positive Omburtamab Clinical Data
NEW YORK, Oct. 28, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the Company or Y-mAbs) (Nasdaq: YMAB) a late-stage clinical […]
miRagen to Present at the DIA/FDA Oligonucleotide-Based Therapeutics Conference Today
An overview of its second-generation miR-29 mimicsClinical development of its microRNA inhibitorsBOULDER, Colo., Oct. 28, 2019 (GLOBE NEWSWIRE) — miRagen […]
Rafael Pharmaceuticals Reaches Milestone of 25 Active Sites for Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Cranbury, NJ, Oct. 28, 2019 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing […]
